李会鹏
职称: 副教授、硕士生导师
邮箱：lhp@hebut.edu.cn
教育背景:
2015 – 2018年，博士（药 剂 学），中国药科大学
2012 – 2015年，硕士（药 剂 学），中国药科大学
2008 – 2012年，学士（药物制剂），中国药科大学
工作履历:
2024–今，副教授，河北工业大学，生命科学与健康工程学院
2022–2023，讲师，河北工业大学，生命科学与健康工程学院
2018 – 2021, 助理研究员，南京大学现代工程与应用科学学院生物医学工程系
研究领域：
生物与医学纳米技术，智能药物递送系统
基金和项目：
1. 国家自然科学基金青年项目，主持；
2. 河北省自然科学基金面上项目，主持；
3. 天津市自然科学基金青年项目，主持；
4. 南京大学国家重大科技项目培育专项，主持；
5. 十四五国家重点研发计划，骨干；
6. 国家自然科学基金区域创新发展联合基金集成项目，骨干。
奖励与荣誉:
威尔曼优秀博士论文
河北工业大学“元光学者”
学术成果:
代表性论文（#为共同一作，*为通讯作者）：
[1] Sun Y, Li L, Fan L, Wang J, Lin X#, Li, H#, Zhou H#. and Yang L#, 2026. Smart PVA/starch hydrogel for real-time monitoring and repair of skin–muscle defects. Chemical Engineering Journal:172544.
[2] Li, H#, Zhao, M., Li, S., Xu, Z., Zhang, T., Li, M., Liu, X., Zhou, H. and Yang, L., 2025. A hybrid nanogel as nanosponge for tumor differentiated sonodynamic therapy. Journal of Colloid and Interface Science:139598.
[3] Yang S*, Li S*, Zhang L, Zhao M, Zhang T, Liu X, Liu B, Zhang H, Gong Y, Zhou H, Li H# and Yang L#. 2026. A Novel Nanozyme‐based Coordination Compound for Synergistic Periprosthetic Joint Infection Treatment and Bone Repair. Advanced Healthcare Materials, 15(2): p.e02379.
[4] Li H#, Yang X, Sun M. Self-strengthened cascade-explosive nanogel using host-guest interaction strategy for synergistic tumor treatment[J]. Chinese Chemical Letters, 2025: 110651.
[5] Zhang L, Zhao M, Yang S, Li S, Zhang T, Zhang H, Gong Y, Li M, Zhou H#, Li H# and Yang L#. 2025. A Mechanically Matched Hydrogel Incorporated with Biomimetic Mineralized Liposome for Synergistic Nucleus Pulposus Repairment. ACS Applied Bio Materials, 8(9), pp.8261-8273.
[6] Kong C, Wang X, Li H#, Zhou H# and Yang L#. 2024. Advanced antibacterial materials for the prevention of nosocomial infections. Interdisciplinary Nursing Research, 3(2), pp.97-108.
[7] Li H, Yang. X, Gao F, et al. Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy [J]. Journal of Controlled Release, 2018.
[8] Li H, Zhou Z, Zhang F, et al. A networked swellable dextrin nanogels loading Bcl2 siRNA for melanoma tumor therapy [J]. Nano Research, 2018.
[9] Li H, Yang X, Zhou Z, et al. Near-infrared light-triggered drug release from a multiple lipid carrier complex using an all-in-one strategy [J]. Journal of Controlled Release, 2017, 261:126-137.
[10] Li H, Wang K, Yang X, et al. Dual-function nanostructured lipid carriers to deliver IR780 for breast cancer treatment: Anti-metastatic and photothermal anti-tumor therapy [J]. Acta Biomaterialia, 2017, 53: 399-413.
[11] Li H, Chen M, Su Z, et al. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery [J]. International Journal of Pharmaceutics, 2016, 511(1): 524-537.
[12] Li H, Yuan D, Sun M, et al. Effect of ligand density and PEG modification on octreotide targeted liposome via somatostatin receptor in vitro and in vivo [J]. Drug Delivery, 2016, 23(9): 1-37.
[13] Li H, Guissi N E I, Su Z, et al. Effects of surface hydrophilic properties of PEG-based mucus-penetrating nanostructured lipid carriers on oral drug delivery [J]. RSC Advances, 2016, 6(87): 84164-84176.
[14] 李会鹏、苏志桂, 陈明磊,等. 粒径差异化的纳米脂质载体的制备和表征[J]. 中国药科大学学报, 2015, 46(4): 436-443.
第二作者
[1] Zhou Z, Li H, Wang K, et al. Bioreducible cross-linked hyaluronic acid/calcium phosphate hybrid nanoparticles for specific delivery of siRNA in melanoma tumor therapy[J]. ACS Applied Materials Interfaces, 2017, 9(17): 14576-14589.
[2] Guissi N E I, Li H, Xu Y, et al. Mitoxantrone-and folate-TPGS2k conjugate hybrid micellar aggregates to circumvent toxicity and enhance efficiency for breast cancer therapy [J]. Molecular Pharmaceutics, 2017, 14(4): 1082-1094.
[3] Yang X, Li H, Qian CG, et al. Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and Photothermal therapy[J]. Nanomedicine: Nanotechnology, Biology and Medicine, 2018, 7(14): 2283-2294.
